Mayne Pharma Group (AU:MYX) has released an update.
Mayne Pharma Group Limited has announced the issuance of 363,345 new fully paid ordinary shares on September 2, 2024. This move, detailed in their latest Appendix 3G filing, signals a change in the company’s unquoted equity securities. The announcement is intended for personal use and marks a new development for the pharmaceutical company.
For further insights into AU:MYX stock, check out TipRanks’ Stock Analysis page.
